Olopatidine .1%
-Dual acting agent
-Perfect monotherapy to treat bacterial conjunctivitis
-No limit on combination
-High safety profile in long term use
-indicated from 2 years up to
Your email address will not be published. Required fields are marked *
English
Arabic